Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF 1 mice

Inflammation

Volumn 35, Issue 6, 2012, Pages 1753-1763

  Hayashi, Toshiharu ^a   Murase, Ayumi ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

B WF1 mouse; Cytokines; Late allergic rhinitis; Lupus; Th1 Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; OVALBUMIN;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; HEALTH STATUS; MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; PRE T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; BLOOD UREA NITROGEN; CREATININE; EOSINOPHILIA; EOSINOPHILS; FEMALE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; NASAL LAVAGE FLUID; NEUTROPHILS; OVALBUMIN; PROTEINURIA; RHINITIS, ALLERGIC, PERENNIAL; SPLEEN; TH1 CELLS; TH2 CELLS;

MUS;

EID: 84872175331     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9494-x     Document Type: Article

References (33)

1. Tan, E.M., A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 25: 1271-1277. (Pubitemid 13221242)
2. Love, P.E., and S.A. Santoro. 1990. Antiphispholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Annals of Internal Medicine 112: 682-688.
3. Mills, J.A. 1994. Systemic lupus erythematosus. The New England Journal of Medicine 330: 1871-1879.
4. Mok, C.C., and C.S. Lau. 2003. Pathogenesis of systemic lupus erythematosus. Journal of Clininical Pathology 56: 481-490. (Pubitemid 36819418)
5. Theofilopoulos, A.N., and F.J. Dixon. 1985. Murine models of systemic lupus erythematosus. Advanced Immunolology 37: 269-290.
6. Kotzin, B.L. 1996. Systemic lupus erythematosus. Cell 85: 303-306. (Pubitemid 26160701)
7. Theopilopoulos, A.N., S. Koundoris, D.H. Kono, and B.R. Lawson. 2001. The role of of IFN-gamma in systemic lupus erythematosus: a challenge to the Th-1/Th-2 paradigm in autoimmunity. Arthritis Research 3: 136-144.
8. Pollard, K.M., P. Hultman, and D.H. Kono. 2003. Using singlegene deletions to identify checkpoints in the progression of systemic autoimmunity. Annals of the New York Academy of Sciences 987: 236-239. (Pubitemid 36584027)
9. 1 mice by plasmids encoding interferon (IFN)-gamma but not by those encoding interleukin (IL)-4. Journal of Comparative Pathology 127: 1-6.
10. Hayashi, T. 2010. Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-γ targeting gene therapy. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/461641.
11. Hayashi, T., K. Hasegawa, Y. Sasaki, T. Mori, T. Adachi, and K. Maeda. 2007. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB×NZW F1 mice. Nephrology, Dialysis, Transplantation 22: 3131-3138. (Pubitemid 350202577)
12. Richards, H.B., M. Satoh, J.C. Jennette, B.P. Croker, H. Yoshida, and W.H. Reeves. 2001. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney International 60: 2173-2180. (Pubitemid 33070460)
13. White, M.V., and M.A. Kaliner. 1992. Mediators of allergic rhinitis. The Journal of Allergy and Clinical Immunology 90: 699-704.
14. Varney, V.A., M.R. Jacobson, R.M. Sudderick, D.S. Robinson, A.M. Irani, L.B. Schwartz, I.S. Mackay, A.B. Kay, and S.R. Durham. 1992. Immunohistology of nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutorophils. American Review of Respiratory Diseases 146: 170-176.
15. Gelfand, E.W. 2004. Inflammatory mediators in allergic rhinitis. The Journal of Allergy and Clinical Immunology 114: S135-S138. (Pubitemid 39440924)
16. Hayashi, T., K. Hasegawa, and Y. Sasaki. 2008. Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice. Inflammation 31: 47-56. (Pubitemid 351238216)
17. Morton, S., B. Palmer, K. Muir, and R.J. Powell. 1998. IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus. Annals of the Rheumatic Diseases 57: 660-663. (Pubitemid 28558969)
18. Sequeira, J.F., D. Cesic, G. Keser, M. Bukelica, S. Karanagnostis, M.A. Khamashta, and G.R. Hughes. 1993. Allergic disorders in systemic lupus erythematosus. Lupus 2: 187-191. (Pubitemid 23225637)
19. Wozniacka, A., A. Sysa-Jedrzejowska, E. Robak, Z. Samochocki, and M. Zak-Prelich. 2003. Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients. Mediators of Inflammation 12: 95-99. (Pubitemid 36783248)
20. Mikecz, K., I. Sonkoly, C. Meszaros, and G. Szegedi. 1985. Serum IgE level in systemic lupus erythematosus. Acta Medica Hungarica 42: 59-65.
21. Elkayam, O., R. Tamir, A.I. Pick, and A. Wysenbeek. 1995. Serum IgE concentrations, disease activity, and atopic disorders in systemic lupus erythematosus. Allergy 50: 94-96.
22. Atta, A.M., M.B. Santiago, F.G. Guerra, M.M. Pereira, and M.L. Sousa Atta. 2010. Autoimmune response of IgE antibodies to cellular self-antigens in systemic lupus erythematosus. International Archive of Allergy and Immunology 152: 401-406.
23. Sekigawa, I., Y. Tokano, T. Yoshiike, N. Iida, H. Hashimoto, and H. Ogawa. 2003. Relationship between serum IgE and autoantibody levels in SLE patients. Clinical and Experimental Rheumatology 21: 683. (Pubitemid 37236477)
24. 1 mice. Lupus 12: 838-845. (Pubitemid 37463101)
25. 1 mice. International Journal of Experimental Pathology 86: 289-296. (Pubitemid 41413624)
26. Sasaki, Y., T. Hayashi, and K. Hasegawa. 2007. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis. Scandinavian Journal of Immunology 66: 628-635. (Pubitemid 350132628)
27. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7: 145-173. (Pubitemid 19138011)
28. Gruber, B.L., L.D. Kaufman, M.J. Marchese, W. Roth, and A.P. Kaplan. 1988. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis and Rheumatism 31: 1000-1006.
29. Robertson, M.R., E.V. Potter, M.L. Roberts, and R. Patterson. 1976. Immunoglobuin E in renal disease. Nephron 16: 256-271.
30. Meerwaldt, R., R.J. Odink, R. Landaeta, F. Aarts, B. Brunekreef, J. Gerritsen, W.M. Van Aalderen, and M.O. Hoekstra. 2002. A lower prevalence of atopy symptoms in children with type 1 diabetes mellitus. Clinical and Experimental Allergy 32: 254-255. (Pubitemid 34429604)
31. Nakashima, T., T. Hayashi, and T. Mizuno. 2002. Reovirus type-2 infection in newborn DBA/1J mice reduces the development of late allergic asthma. International Journal of Experimental Pathology 93: 234-242.
32. Tirosh, A., D. Mandel, F.B. Mimouni, E. Zimlichman, T. Shochat, and I. Kochba. 2006. Autoimmune diseases in asthma. Annual Internal Medicine 144: 877-883. (Pubitemid 46768127)
33. Hayashi, T. 2012. Molecular mechanisms in allergic rhinitis: modulation by microbes. In Advances in medicine and biology, vol.40, ed. L.V. Berhard, 59-90. NY: Nova SCi Pub. ISBN:978-1-62100-421-9.